<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142084">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01251289</url>
  </required_header>
  <id_info>
    <org_study_id>REB 09-072</org_study_id>
    <nct_id>NCT01251289</nct_id>
  </id_info>
  <brief_title>The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center</brief_title>
  <official_title>The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <brief_summary>
    <textblock>
      A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients
      in an Inner City Tertiary Care Center
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective chart review of the prevalence of Group B Streptococcus (GBS)
      positive patients
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">628</enrollment>
  <condition>Group B Streptococcus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Group B streptococcus positive pregnant women
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  GBS positive pregnant women

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Yudin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <verification_date>December 2009</verification_date>
  <lastchanged_date>June 8, 2012</lastchanged_date>
  <firstreceived_date>November 30, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
